PPARGC1A and cardiovascular disorder: Our results suggest that PGC-1α activity is also likely to be relevant in the limitation of cardiac damage following an STEMI, and that its monitorization is feasible and likely to be a relevant prognosis factor both for cardiovascular disease and for the extent of cardiac damage following STEMI.